Arcturus Therapeutics Holdings Inc.
ARCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768224
No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Arcturus Therapeutics Holdings Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- +12 vs. Q4 2022
- Shares held
- 23.3M
- +682.9K (+3.0%) vs. Q4 2022
- Total value
- $557.9M
- +$174.0M (+45.3%) vs. Q4 2022
- New holders
- 25
- 44 more added
- Sold out
- 13
- 36 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $167.9M |
| Q1 2026 | 124 | $187.3M |
| Q4 2025 | 121 | $145.1M |
| Q3 2025 | 137 | $476.8M |
| Q2 2025 | 145 | $336.3M |
| Q1 2025 | 147 | $282.9M |
| Q4 2024 | 149 | $452.5M |
| Q3 2024 | 164 | $609.3M |
| Q2 2024 | 171 | $640.0M |
| Q1 2024 | 179 | $918.7M |
| Q4 2023 | 166 | $801.6M |
| Q3 2023 | 147 | $643.1M |
| Q2 2023 | 144 | $677.6M |
| Q1 2023 | 124 | $557.9M |
| Q4 2022 | 113 | $383.9M |
| Q3 2022 | 117 | $328.1M |
| Q2 2022 | 128 | $353.6M |
| Q1 2022 | 129 | $578.1M |
| Q4 2021 | 139 | $736.2M |
| Q3 2021 | 157 | $909.0M |
| Q2 2021 | 139 | $694.0M |
| Q1 2021 | 162 | $776.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Arcturus Therapeutics Holdings Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 4,109 | $98.0K | 0.00% | +789+23.8% | Added |
| Amalgamated Bank | 3,163 | $76.0K | 0.00% | −490−13.4% | Reduced |
| Great West Life Assurance Co | 2,679 | $64.0K | 0.00% | +616+29.9% | Added |
| Aquatic Capital Management LLC | 2,300 | $55.0K | 0.00% | −11,500−83.3% | Reduced |
| Advisor Group Holdings, Inc. | 1,806 | $43.3K | 0.00% | −175−8.8% | Reduced |
| Ameritas Investment Partners, Inc. | 1,638 | $39.3K | 0.00% | 00.0% | Unchanged |
| Point72 Middle East FZE | 1,399 | $33.5K | 0.00% | −3,274−70.1% | Reduced |
| Metropolitan Life Insurance Co | 1,394 | $33.4K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,287 | $30.8K | 0.00% | +26+2.1% | Added |
| Itau Unibanco Holding S.A. | 1,111 | $26.6K | 0.00% | −8−0.7% | Reduced |
| Fifth Third Bancorp | 500 | $12.0K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 360 | $8.63K | 0.00% | +91+33.8% | Added |
| Nisa Investment Advisors, LLC | 200 | $5.00K | 0.00% | 00.0% | Unchanged |
| Endurance Wealth Management, Inc. | 165 | $4.00K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 150 | $3.60K | 0.00% | 00.0% | Unchanged |
| Ameliora Wealth Management Ltd. | 150 | $3.60K | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 100 | $2.40K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 100 | $2.00K | 0.00% | +100 | New |
| National Bank of Canada | 70 | $1.68K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 58 | $1.39K | 0.00% | −29−33.3% | Reduced |
| Bell Investment Advisors, Inc | 38 | $911 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 26 | $623 | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 20 | $480 | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 10 | $240 | 0.00% | +6+150.0% | Added |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −28,612−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −21,284−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −21,040−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −12,193−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −11,814−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,945−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −743−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Comerica Securities,inc. | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Sargent Bickham Lagudis LLC | – | – | – | – | Not filed |